Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

165.73
+2.351.44%
Pre-market: 166.000.2700+0.16%04:16 EDT
Volume:10.02M
Turnover:1.66B
Market Cap:11.52B
PE:9.09
High:167.91
Open:164.60
Low:163.74
Close:163.38
52wk High:169.68
52wk Low:88.60
Shares:69.53M
Float Shares:69.53M
Volume Ratio:1.04
T/O Rate:14.41%
Dividend:0.56
Dividend Rate:0.34%
EPS(TTM):18.23
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Health Care Down on Growth Doubts - Health Care Roundup

Dow Jones
·
Aug 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)

TIPRANKS
·
Aug 15

Sector Update: Healthcare

MT Newswires Live
·
Aug 15

DRI Healthcare Posts Record Q1 Income and Bolsters Balance Sheet With New Funding

TIPRANKS
·
Aug 15

Vital Healthcare Property Trust (NZSE:VHP) Stock Faces FFO Shock Despite AFFO Support

Simply Wall St.
·
Aug 15

Sector Update: Healthcare

MT Newswires Live
·
Aug 15

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)

TIPRANKS
·
Aug 15

Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX) and Prothena (PRTA)

TIPRANKS
·
Aug 15

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC)

TIPRANKS
·
Aug 14

CIBC Remains a Hold on NorthWest Healthcare Properties REIT (NWHUF)

TIPRANKS
·
Aug 14

Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says

MT Newswires Live
·
Aug 14

Shandong Boan Biotech Sets Board Meeting to Approve 2026 Interim Results and Mull Dividend

TIPRANKS
·
Aug 14

Krystal Biotech Price Target Announced at $400.00/Share by RBC Capital

Dow Jones
·
Aug 14

Climb Bio Advances Phase 2 Renal Disease Trial

TIPRANKS
·
Aug 14

New Century Healthcare Flags Bank Account Freeze Linked to Partner Probe

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
Aug 14

Moleculin Biotech Q2 EPS $(1.40) Misses $(1.01) Estimate

Benzinga Earnings
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 14

Krystal Biotech (KRYS) Has a New Rating from RBC Capital

TIPRANKS
·
Aug 14

Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial

GlobeNewswire
·
Aug 14